BrightOwl Loader Loading


Currently Team Leader in the Department of Discovery Sciences. Strong and genuine passion for drug discovery. Specialties: Cellular Assay development, Molecular and Cellular biology, Target Selection, Drug Discovery, Team Management, Team Leadership.


Current Experience

  • Team Leader, Discovery Sciences, Oncology and Neuroscience
    Since August 2015

Past Experience

  • Research Laboratory Head
    October 2010 --- July 2015
    Research Laboratory Head at Boehringer-Ingelheim leading a team of motivated and highly-skilled scientists to strategically identify and validate novel targets for Oncology. Successfully led innovative projects from target identification/validation to preclinical development. Project management with CRO. Fostered Boehringer-Ingelheim collaboration network with academic institutions and biotech companies. Acted as chair of the Boehringer-Ingelheim internal working groups to ensure best practice in projects. Recognized with Boehringer-Ingelheim Silver Award 2013 for important contribution to discover innovative drugs for cancer patients

  • Research associate
    March 2006 --- November 2010
    Post-doctoral fellow working on the study of the regulation of NADPH oxidase-1 (Nox1) activity: i) Made use of HTS technology for the identification of potent and specific inhibitor of Nox1 (results published in a first-authored article in ACS Chem Biol (2010) and summarized in two Probe Reports to the NIH (2010) ii) Successfully led other research projects resulting in three first-authored papers in peer-reviewed journals and featured in “News and Views” (see Publication list) iii) High familiarity with 2D/3D proliferation and reporter assays relevant for Oncology iv) Trained and mentored several undergraduate and graduate students, who are now pursuing their independent research careers.

  • PhD student
    May 2003 --- November 2006
    Visiting PhD student in the lab of Professor Michael Geoff Rosenfeld interested in the elucidation of epigenetic mechanisms implicated in the pathogenesis of Alzheimer´s disease. Results from these studies were summarizied in a publication in EMBO Reports (2006)

  • PhD student
    November 2001 --- November 2006
    PhD student working on the regulation of the cleavage of the amyloid-precursor protein (APP): i) Generated a cellular model system to identify small molecule or growth factors responsible for the proteolytic cleavage of APP. ii) Mastered molecular and cellular biology techniques for generation of stable and inducible clones. iii) Results of this research project have been published in a first-authored publication.


LinkedIn Assessment :
Research Project ManagementTarget Identificationmolecular biologyDrug DiscoveryCell biologyCell CultureBiochemistryProtein PurificationLifesciencesImmunologyProtein chemistryWestern BlottingELISAPCRAssay developmentPurificationCancerProtein ExpressionCellCell SignalingClinical DevelopmentLife SciencesoncologyBiotechnologyNeuroscienceMolecular CloningIn VitroHigh Throughput ScreeningscienceResearch


  • Certificate Program in Drug Discovery and Development from University of California, San Diego in 2009
  • PhD in Genetics from Università degli Studi di Napoli 'Federico II' in 2005

Area / Region

Cambridge, United Kingdom


Driving License
  • No